Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propofol Injection (Veterinary) is a small molecule intravenous anesthetic developed and manufactured by Guangdong Ji-Bao Pharmaceutical. It functions as a positive allosteric modulator of the GABA-A receptor, enhancing the inhibitory neurotransmission of gamma-aminobutyric acid (GABA) within the central nervous system to produce rapid-onset anesthesia and sedation. This specific formulation is tailored for veterinary applications, primarily for the induction and maintenance of general anesthesia in animals such as pets and small animals. Guangdong Ji-Bao Pharmaceutical is recognized for its expertise in perioperative medicine and serves as a national standard-setter for propofol emulsion injections in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propofol injection (veterinary).